Indefinite Delivery Contract SPE2DU25D1008

The Indefinite Delivery Contract (IDC) SPE2DU25D1008 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The solicitation for this IDC, referred to as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), seeks to establish multiple Prime Vendor Contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency (DHA), the U.S. Coast Guard, and the U.S. Naval Fleet. The contract encompasses the supply of brand-name, generic, and specialty pharmaceuticals, as well as related medical commodities such as syringes, vials, and test kits across multiple therapeutic areas. The contract will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. The procurement is fully competitive, and the primary evaluation criterion is the lowest overall price based on distribution fees.